Inhibition of human and bovine insulin fibril formation by designed peptide conjugates

Molecular Pharmaceutics

Volumn 10, Issue 10, 2013, Pages 3903-3912

  Mishra, Narendra Kumar ^a   Joshi, Khashti Ballabh ^a,b   Verma, Sandeep ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Aggregation; Inhibition; Insulin; Microscopy; NMR; Peptide; Spectroscopy

Indexed keywords

BOVINE INSULIN; HUMAN INSULIN; PEPTIDE; THIOFLAVINE;

ALPHA HELIX; ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; CIRCULAR DICHROISM; CONJUGATE; FIBER; INHIBITION KINETICS; NUCLEAR MAGNETIC RESONANCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

ANIMALS; CATTLE; CIRCULAR DICHROISM; HUMANS; INSULIN; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ATOMIC FORCE; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY;

EID: 84888389316     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400364w     Document Type: Article

References (63)

1. Selkoe, D. J. Proteins folding in fatal ways. Nature 2003, 426, 900-904.
2. Kelly, J. W. Towards understanding of molecular amyolgenesis. Nat. Struct. Biol. 2002, 9, 323-325.
3. Levine, H. The challenge of inhibiting Aβ polymerization. Curr. Med. Chem. 2002, 9, 1121-1133.
4. Tycko, R.; Wickner, R. B. Molecular structure of amyloid and prions fibrils: Consensus versus controversy. Acc. Chem. Res. 2013, 46, 1487-1496.
5. Sipe, J. D.; Cohen, A. S. Review: History of the amyloid fibril. J. Struct. Biol. 2000, 130, 88-98.
6. Morrisa, K.; Serpell, L. From natural to designer self assembles biopolymer the structural characterization of fibrous proteins and peptides using fibre diffraction. Chem. Soc. Rev. 2010, 39, 3445-3453.
7. Bucciantini, M.; Giannoni, E.; Chiti, F.; Baroni, F.; Formigli, L.; Zurdo, J.; Taddei, N.; Ramponi, G.; Dobson, C. M.; Stefani, M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002, 416, 507-511.
8. Sirangelo, I.; Irace, G. Inhibition of aggregate formation as therapeutic target in protein misfolding diseases: effect of tetracycline and trehalose. Expert Opin. Ther. Targets 2010, 14, 1311-1321.
9. Sirangelo, I.; Iannuzzi, C.; Vilasi, S.; Irace, G.; Giuberti, G.; Misso, G.; D'Alessandro, A.; Abbrezzese, A.; Caraglia, M. W7FW14F Apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac. J. Cell Physiol. 2009, 221, 412-423.
10. Vilasi, A.; Vilasi, S.; Romano, R.; Acernese, F.; Barone, F.; Balestrieri, M. L.; Maritato, R.; Irace, G.; Sirangelo, I. Unraveling amyloid toxicity pathway in NIH3T3 cells by a combined proteomic and 1H-NMR metabolomic approach. J. Cell. Physiol. 2013, 228, 1359-1367.
11. Malmo, C.; Vilasi, S.; Iannuzzi, C.; Tacchi, S.; Cametti, C.; Irace, G.; Sirangelo, I. Tetracycline inhibits W7FW14F apomyoglobin fibril extension and keeps the amyloid protein in a pre-fibrillar, highly cytotoxic state. FASEB J. 2006, 20, 346-347.
12. Grudzielanek, S.; Velkova, A.; Shukla, A.; Smirnovas, V.; Tatarek-Nossol, M.; Rehage, H.; Kapurniotu, A.; Winter, R. Cytotoxicity of insulin within its self-assembly and amyloidogenic pathways. J. Mol. Biol. 2007, 370, 372-384.
13. Wang, S. S.-S.; Liu, K.-N.; Han, T.-C. Amyloid fibrillation and cytotoxicity of insulin are inhibited by the amphiphilic surfactants. Biochim. Biophys. Acta 2010, 1802, 519-530.
14. Kachooei, E.; Moosavi-Movahedi, A. A.; Khodagholi, F.; Ramshini, H.; Shaerzadeh, F.; Sheibani, N. Oligomeric forms of insulin amyloid aggregation disrupt outgrowth and complexity of neuron-like PC12 cells. PloS One 2012, 7, e41344.
15. Waugh, D. F. Regeneration of insulin from insulin fibrils by the action of alkli. J. Am. Chem. Soc. 1948, 70, 1850-1857.
16. Nielsen, L.; Khurana, R.; Coats, R. A.; Frokjaer, S.; Brange, J.; Vyas, S.; Uversky, V. N. Effect of environmental factor on the kinetics of insulin fibril formation: Elucidation of molecular mechanism. Biochemistry 2001, 40, 6036-6046.
17. Ivanova, M. I.; Sievers, S. A.; Sawaya, M. R.; Wall, J. S.; Eisenberg, D. Molecular basis for insulin fibril assembly. Proc. Natl. Acad. Sci. 2009, 106, 18990-18995.
18. Brange, J.; Andersen, L.; Laursen, E. D.; Meyn, G.; Rasmussen, E. Towards understanding of insulin fibrillation. J. Pharm. Sci. 1997, 86, 517-525.
19. Wilhelm, K. R.; Yanamandra, K. M.; Gruden, A.; Zamotin, V.; Malisauskas, C. M.; Darinskas, V. A.; Forsgren, L.; Morozova-Roche, L. A. Immune reactivity towards insulin, its amyloid and protein S100B in blood in sera of Parkinson's disease patients. Eur. J. Neurol. 2007, 14, 327-334.
20. Jansen, R.; Dzwolak, W.; Winter, R. Amyloidogenic self assembly of insulin aggregates probed by high resolution atomic force microscopy. Biophys. J. 2005, 88, 1344-1353.
21. Nielsen, L.; Frokjaer, S.; Brange, J.; Uversky, V. N.; Fink, A. L. Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 2001, 40, 8397-8409.
22. Babenko, V.; Piejko, M.; Wöjcik, S.; Mak, P.; Dzwolak, W. Vortex-induced amyloid superstructures of insulin and its component A and B chains. Langmuir 2013, 29, 5271-5278.
23. Librizzi, F.; Rischel, C. The kinetics behavior of insulin fibrillation is determined by heterogeneous nucleation pathways. Protein Sci. 2005, 14, 3129-3134.
24. Burke, M. J.; Rougvie, M. A. Cross β Protein structure. Biochemistry 1972, 11, 2435-2439.
25. Chwedoruk, W. S.; Nieznanska, H.; Wojcik, S.; Dzwolak, W. Cross seeding of fibrils from two types of insulin induced new amyloid strains. Biochemistry 2012, 51, 9460-9469.
26. Krebs, M. R. H.; Maphee, C. E.; Miller, A. F.; Dunlop, I. E.; Dobson, C. M.; Donald, A. M. The formation of spherulites by amyloid fibres of bovine insulin. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 14420-14424.
27. Kurouski, D.; Dukor, R. K.; Lu, X.; Nafie, L. A.; Lednev, I. K. Normal and reversed supramolecular chirality of insulin fibrils probed by vibrational circular dichroism at the protofilament level of fibrils structure. Biophys. J. 2012, 103, 522-531.
28. Fodera, V. M.; Weert, V. D.; Vestergaard, B. Large scale polymorphism and auto-catalytic effect in insulin fibrillogenesis. Soft Matter 2010, 6, 4413-4419.
29. Loksztejn, A.; Dzwolak, W. Chiral bifurcation in aggregating insulin: an induced circular dichroism study. J. Mol. Biol. 2008, 379, 9. 16.
30. Amdursky, N.; Gazit, E.; Rosenman, G. Formation of lowdimensional crystalline nucleus region during insulin amyloidogenesis process. Biochem. Biophys. Res. Commun. 2012, 419, 232-237.
31. Sluzky, V.; Tamada, J. A.; Klibanov, A. M.; Langer, R. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc. Natl. Acad. Sci. 1991, 88, 9377-9381.
32. Arora, A.; Ha, C.; Park, C. B. Inhibition of insulin amyloid formation by small stress molecules. FEBS Lett. 2004, 564, 121-125.
33. Vilasi, S.; Lannuzzi, C.; Portaccio, M.; Irace, G.; Sirangelo, I. Effect of trehalose on W7FW14F apomyoglobin and insulin fibrillization: New insights into the inhibition activity. Biochemistry 2008, 47, 1789-1796.
34. Giger, K.; Vanam, R. P.; Seyrek, E.; Dubin, P. L. Suppression of insulin aggregation by Heparin. Biomacromolecules 2008, 9, 2338. 2344.
35. Hong, Y.; Meng, L.; Chen, S.; Leung, C. W. T.; Da, L. T.; Faisal, M.; Silva, D. A.; Liu, J.; Lam, J. W.; Huang, Y. X.; Tang, B. Z. Monitoring and inhibition of insulin fibrillation by small organic fluorogen with aggregation-induced emission characteristics. J. Am. Chem. Soc. 2012, 134, 1680-1689.
36. Gibson, T. J.; Murphy, R. M. Inhibition of insulin fibrillogenesis with targeted peptide. Protein Sci. 2006, 15, 1133-1141.
37. Velkova, A.; Nossol, M. T.; Andreetto, E.; Kapurniotu, A. Exploiting cross-amyloid interactions to inhibit protein aggregation but not function: nanomolar affinity inhibition of insulin aggregation by an IAPP mimic. Angew. Chem., Int. Ed. 2008, 47, 7114-7118.
38. Wang, S. H.; Dong, X. Y.; Sun, Y. Effect of (-) epigallocatechin-3- gallate on human insulin fibrillation/aggregation kinetics. Biochem. Eng. J. 2012, 63, 38-49.
39. Varughese, M. M.; Newman, J. Inhibitory effect of arginine on the aggregation of bovine insulin. J. Biophys. 2012, 434289. DOI: 10.1155/2012/434289.
40. Grudzielanek, S.; Smirnovas, V.; Winter, R. Solvent-assisted pressure tuning of insulin fibrillation: from novel aggregation pathways to biotechnological applications. J. Mol. Biol. 2006, 356, 497-509.
41. Nayak, A.; Sorci, M.; Krueger, S.; Belfort, G. A. Universal pathways for amyloid nucleus and precursor formation for insulin. Proteins 2009, 74, 556-565.
42. Jorgensen, A. M. M.; Olsen, H. B.; Bahlschmidt, P.; Led, J. J. Solution structure of the superactive monomeric Des-[Phe(B25)] Human insulin mutants: Elucidation of the structural basis for the monomerization Des-[Phe(B25)] of insulin and the dimerisation of native insulin. J. Mol. Biol. 1996, 257, 684-699.
43. Mondal, S.; Barman, A. K.; Verma, S. Peptide-based synthetic design construction and morphology of soft structures. Chimia 2012, 66, 930-935.
44. Joshi, K. B.; Verma, S. Ditryptophan conjugation triggers conversions of biotin fibres into soft spherical structures. Angew. Chem., Int. Ed. 2008, 47, 2860-2863.
45. Ghosh, S.; Reches, M.; Gazit, E.; Verma, S. Bioinspired design of nanocages by self assembling of triskelion peptide elements. Angew. Chem., Int. Ed. 2007, 46, 2002-2004.
46. Ghosh, S.; Verma, S. Phase fiiber growth in peptide conjugates: aggregation and disaggregation studies. J. Phys. Chem. B. 2007, 111, 3750-3757.
47. Ghosh, S.; Singh, S. K.; Verma, S. Self assembly and potassium ion triggered disruption of peptide based-soft structures. Chem. Commun. 2007, 2296-2298.
48. Bouchard, M.; Zurado, J.; Nettleleton, E. J.; Dobson, C. M.; Robinson, C. V. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 2000, 9, 1960-1967.
49. Krebs, M. R. H.; Bromley, E. H. C.; Donald, A. M. The binding of thioflavin-T to amyloid fibrils: localization and implications. J. Struct. Biol. 2005, 149, 30-37.
50. Khurana, R.; Coleman, C. C.; Zanetti, I. S.; Carter, A.; Krishna, V.; Grover, R. K.; Roy, R.; Singh, S. Mechanism of thioflavin-T binding to amyloid fibrils. J. Struct. Biol. 2005, 151, 229-238.
51. Biancalana, M.; Koide, S. Molecular mechanism of thioflavin-t bindings to amyloid fibres. Biochim. Biophys. Acta 2010, 1804, 1405-1412.
52. Sulatskaya, A. I.; Kuznetsova, I. M.; Turoverov, K. K. Interaction of thioflavin-t with amyloid fibrils: stoichiometry and affinity of dye binding, absorption spectra of bound dye. J. Phys. Chem. B 2011, 115, 11519-11524.
53. Weinberg, R. B. Exposure and electronic interaction of tyrosine and tryptophan residues in human apolipoprotein A-IV. Biochemistry 1988, 27, 1515-1521.
54. Bekard, I. B.; Dunstan, D. E. Tyrosine auto fluorescence as a measure of bovine insulin fibrillation. Biophys. J. 2009, 97, 2521-2531.
55. Bodenreider, C.; Beer, D.; Keller, T. H.; Sonntag, S.; Wena, D.; Li Jian, Y.; Yau, Y. H.; Shochat, S. G.; Huang, D.; Zhou, T.; Caflisch, A.; Su, X.-C.; Ozawa, K.; Otting, G.; Vasudevan, S. G.; Lescar, J.; Lim, S. P. A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease. Anal. Biochem. 2009, 395, 195-204.
56. Su, X.-C.; Ozawa, K.; Yagi, H.; Lim, S. P.; Wen, D.; Ekonomiuk, D.; Huang, D.; Keller, T. H.; Sonntag, S.; Caflisch, A.; Vasudevan, S. G.; Otting, G. NMR study of the complexes between low molecular mass inhibitors and the west line Virus NS2B-NS3 protease. FEBS J. 2009, 276, 4244-4255.
57. Keller, D.; Clausen, R.; Josefsen, K.; Led, J. J. Flexibility and bioactivity of insulin: an NMR investigation of the solution structure and folding of an unusually flexible human insulin mutant with increased biological activity. Biochemistry 2001, 40, 10732-10740.
58. Mahalakshmi, R.; Raghothama, S.; Balaram, P. NMR analysis of aromatic interaction in designed peptide β-hairpins. J. Am. Chem. Soc. 2006, 128, 1125-1138.
59. Coleman, J. E.; Anderson, R. A.; Ratcliffe, R. G.; Armitage, I. M. Structure of gene 5 protein-oloigodeoxynucleotide complexes as a determined by proton 19F, and 31P nuclear magnetic resonance. Biochemistry 1976, 15 (25), 5419-5430.
60. Becker, R. H. Insulin glulisine complementing basal insulins: a review of structure and activity. Diabetes Technol. Ther. 2007, 9, 109. 121.
61. Brange, J.; Langjar, L.; Pearlman, R.; Wang, Y. J., Eds. Insulin structure and stability (Chapter 11). Stability and Characterization of Protein and Peptide Drugs: Case Histories; Springer: New York, 1993; p 315.
62. Levy-Sakin, M.; Shreberk, M.; Daniel, Y.; Gazit, E. Targeting insulin amyloid assembly by small aromatic molecule: towards rational design of aggregation inhibitors. Islets 2009, 1, 210-215.
63. Wu, C.; Lei, H.; Duan, Y. The role of Phe in the formation well ordered oligomers of amyloidogenic hexapeptide (NFGAIL) observed in molecular dynamics simulations with explicit solvent. Biophys. J. 2005, 88, 2897-2906.